Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Warner-Lambert announces collaboration with Forest

April 8, 1998

Neurokinin A: a peptide with a potential role in the perception of pain

April 8, 1998

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

First clinical trials performed with BMS-181885

April 7, 1998

Metabasis Therapeutics and Pfizer extend ARA research collaboration

April 7, 1998

Orphan Medical announces Xyrem clinical trial results

April 3, 1998

Centrally active adrenergic agents in development at Pierre Fabre

April 3, 1998

Neurogen prepares new class of brain GABA receptor ligands

April 3, 1998

Neurex completes patient enrollment in ziconotide phase III trial

April 2, 1998

Recent data suggest mechanism of action of nefiracetam's beneficial effects on cognition

April 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...